Kiora Pharmaceuticals(KPRX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

KPRX Kiora Pharmaceuticals

交易中 10-02 11:06:42 EDT

2.55

-0.03

-1.01%

最高2.55	最低2.55	成交量2,488
今开2.55	昨收2.58	日振幅0.16%
总市值1,132万	流通市值1,096万	总股本443.24万
成交额6,348	换手率0.06%	流通股本429.20万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"KPRX","market":"US","secType":"STK","nameCN":"Kiora Pharmaceuticals","latestPrice":2.554,"timestamp":1790952829403,"preClose":2.58,"halted":0,"volume":2488,"delay":0,"changeRate":-0.010077519379845057,"floatShares":4291999,"shares":4432400,"eps":-2.41,"marketStatus":"交易中","change":-0.026,"latestTime":"10-02 11:06:42 EDT","open":2.55,"high":2.554,"low":2.55,"amount":6348.2817776,"amplitude":0.00155,"askPrice":2.59,"askSize":14,"bidPrice":2.54,"bidSize":3,"shortable":3,"etf":0,"ttmEps":-2.41,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1790971200000},"marketStatusCode":2,"adr":0,"listingDate":1438315200000,"exchange":"NASDAQ","adjPreClose":2.58,"postHourTrading":{"tag":"盘后","latestPrice":2.58,"preClose":2.58,"latestTime":"19:30 EDT","volume":12,"amount":30.96,"timestamp":1790897404377,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.43322},"requestUrl":"/m/hq/s/KPRX/tweets","defaultTab":"tweets","newsList":[{"id":"1188868041","title":"Kiora Pharmaceuticals与CKD达成独家许可协议：KIO-301韩国眼科权益授予","url":"https://stock-news.laohu8.com/highlight/detail?id=1188868041","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1188868041?lang=zh_cn&edition=full","pubTime":"2026-08-19 19:03","pubTimestamp":1787137394,"startTime":"0","endTime":"0","summary":"Kiora Pharmaceuticals近日通过美国证券交易委员会文件披露，公司已向CKD授予KIO-301在韩国市场的独家许可权，用于眼科领域。这一战略举措意味着，韩国市场将迎来KIO-301的本地化开发与商业化推进。KIO-301是Kiora Pharmaceuticals的核心在研管线资产，其针对眼科适应症的潜力正逐步获得业界认可。Kiora Pharmaceuticals管理层在提交的文件中强调，此次合作符合公司聚焦核心治疗领域、依托合作伙伴网络实现全球化价值释放的长期战略。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KPRX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133746485","title":"Kiora Pharmaceuticals获韩国Kio-301净销售额两位数特许权使用费资格——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1133746485","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1133746485?lang=zh_cn&edition=full","pubTime":"2026-08-19 19:03","pubTimestamp":1787137389,"startTime":"0","endTime":"0","summary":"Kiora Pharmaceuticals——依据美国证券交易委员会（SEC）文件显示，该公司已具备资格，可从其药物Kio-301在韩国的净销售额中获取两位数的特许权使用费。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KPRX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111952486","title":"Kiora制药公司提交售股股东转售至多1180万股招股说明书 - 美国证券交易委员会备案","url":"https://stock-news.laohu8.com/highlight/detail?id=1111952486","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1111952486?lang=zh_cn&edition=full","pubTime":"2026-05-19 04:35","pubTimestamp":1779136532,"startTime":"0","endTime":"0","summary":"Kiora制药公司已向美国证券交易委员会提交文件，为其售股股东转售最多1180万股公司股票进行备案。\n该招股说明书旨在为现有股东出售其持有的股份提供正式渠道，涉及转售的股份数量上限为1180万股。此举通常意味着部分早期投资者或内部人士可能计划减持其持股。\n通过向美国证券交易委员会提交此类文件，公司为特定股东的大宗股票销售建立了合规框架，确保交易过程符合监管要求。此类备案通常会引起市场对潜在股票供应增加的关注，并可能影响该股的短期交易动态。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","KPRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137901406","title":"Kiora Pharmaceuticals将非公开发行438,471股普通股——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1137901406","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1137901406?lang=zh_cn&edition=full","pubTime":"2026-04-07 19:03","pubTimestamp":1775559813,"startTime":"0","endTime":"0","summary":"根据美国证券交易委员会（SEC）最新披露的文件，生物制药公司Kiora Pharmaceuticals（股票代码：KPRX）计划通过非公开发行的方式，向特定投资者配售438,471股公司普通股。\n此次私募配售旨在为公司后续的研发活动及一般营运资金需求筹措资金。该举措反映了公司在资本市场的积极运作，以期支持其长期发展战略。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","KPRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517416736","title":"Kiora Pharmaceuticals, Inc.盘中异动 早盘快速上涨5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517416736","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517416736?lang=zh_cn&edition=full","pubTime":"2025-03-07 00:23","pubTimestamp":1741278229,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日00时23分，Kiora Pharmaceuticals, Inc.股票出现波动，股价大幅拉升5.36%。Kiora Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.32%。其相关个股中，Surrozen Inc C/Wts 01/08/2031 、Plus Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.涨幅较大，Aeon Biopharma, Inc.、Plus Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为2968.68%、2019.90%、172.52%，振幅较大的相关个股有Tonix Pharmaceuticals Holding Corp.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Aeon Biopharma, Inc.，振幅分别为71.44%、68.33%、67.37%。Kiora Pharmaceuticals, Inc.公司简介：Kiora Pharmaceuticals Inc 是一家临床阶段的生物技术公司，致力于开发和商业化用于治疗孤儿性视网膜疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307002350963c6223&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307002350963c6223&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KPHMW","KPHCW","KPRX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517017929","title":"Kiora Pharmaceuticals, Inc.盘中异动 临近收盘大幅上涨7.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517017929","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517017929?lang=zh_cn&edition=full","pubTime":"2025-03-06 05:01","pubTimestamp":1741208492,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日05时01分，Kiora Pharmaceuticals, Inc.股票出现波动，股价快速拉升7.46%。Kiora Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.85%。其相关个股中，Nkgen Biotech Inc C/Wts 31/05/2028、Chimerix, Inc.、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为1004.53%、326.36%、323.40%，振幅较大的相关个股有Nkgen Biotech Inc C/Wts 31/05/2028、Nkgen Biotech, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为974.63%、82.59%、54.27%。Kiora Pharmaceuticals, Inc.公司简介：Kiora Pharmaceuticals Inc 是一家临床阶段的生物技术公司，致力于开发和商业化用于治疗孤儿性视网膜疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306050133989d9908&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306050133989d9908&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KPHCW","KPRX","BK4007","KPHMW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516669756","title":"Kiora Pharmaceuticals, Inc.盘中异动 临近收盘股价大跌5.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516669756","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516669756?lang=zh_cn&edition=full","pubTime":"2025-03-04 05:01","pubTimestamp":1741035713,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日05时01分，Kiora Pharmaceuticals, Inc.股票出现异动，股价快速下挫5.54%。Kiora Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.20%。其相关个股中，Bioxcel Therapeutics, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com涨幅较大，Bioxcel Therapeutics, Inc.、Allarity Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为4718.85%、220.98%、191.92%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、119.50%、70.53%。Kiora Pharmaceuticals, Inc.公司简介：Kiora Pharmaceuticals Inc 是一家临床阶段的生物技术公司，致力于开发和商业化用于治疗孤儿性视网膜疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304050154989a6595&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304050154989a6595&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","KPHMW","KPHCW","KPRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512831434","title":"Kiora Pharmaceuticals, Inc.盘中异动 临近收盘股价大跌5.65%报3.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512831434","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512831434?lang=zh_cn&edition=full","pubTime":"2025-02-20 05:00","pubTimestamp":1739998849,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日05时00分，Kiora Pharmaceuticals, Inc.股票出现异动，股价大幅跳水5.65%。截至发稿，该股报3.51美元/股，成交量1.8411万股，换手率0.61%，振幅5.38%。Kiora Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.89%。Kiora Pharmaceuticals, Inc.公司简介：Kiora Pharmaceuticals Inc 是一家临床阶段的生物技术公司，致力于开发和商业化用于治疗孤儿性视网膜疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220050049988b6e2b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220050049988b6e2b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KPRX","KPHMW","KPHCW","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510380350","title":"Kiora Pharmaceuticals, Inc.盘中异动 早盘股价大跌6.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510380350","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510380350?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:41","pubTimestamp":1739284866,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时41分，Kiora Pharmaceuticals, Inc.股票出现异动，股价大幅跳水6.94%。Kiora Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.30%。其相关个股中，Ocean Biomedical, Inc.、Dominari Holdings Inc.、Lipella Pharmaceuticals Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为2241.53%、588.63%、229.57%，振幅较大的相关个股有Ocean Biomedical, Inc.、In8Bio, Inc.、Dominari Holdings Inc.，振幅分别为32.43%、31.80%、29.38%。Kiora Pharmaceuticals, Inc.公司简介：Kiora Pharmaceuticals Inc 是一家临床阶段的生物技术公司，致力于开发和商业化用于治疗孤儿性视网膜疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112241069881bef5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112241069881bef5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KPHCW","BK4007","KPRX","KPHMW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508494331","title":"Kiora Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508494331","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508494331?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:34","pubTimestamp":1738593275,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时34分，Kiora Pharmaceuticals, Inc.股票出现波动，股价快速下挫5.37%。Kiora Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.39%。其相关个股中，Hcw Biologics Inc.、Gh Research Plc、Briacell Therapeutics Corp.涨幅较大，Hcw Biologics Inc.、Briacell Therapeutics Corp.、Cyclerion Therapeutics, Inc.较为活跃，换手率分别为347.64%、296.15%、135.28%，振幅较大的相关个股有Hcw Biologics Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Invivyd, Inc.，振幅分别为57.23%、33.33%、26.50%。Kiora Pharmaceuticals, Inc.公司简介：Kiora Pharmaceuticals Inc 是一家临床阶段的生物技术公司，致力于开发和商业化用于治疗孤儿性视网膜疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223435abc107ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223435abc107ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KPRX","KPHCW","BK4007","KPHMW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507668905","title":"Kiora Pharmaceuticals, Inc.盘中异动 临近收盘大幅上涨6.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507668905","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507668905?lang=zh_cn&edition=full","pubTime":"2025-01-30 04:33","pubTimestamp":1738182811,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日04时33分，Kiora Pharmaceuticals, Inc.股票出现波动，股价大幅上涨6.77%。Kiora Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.52%。其相关个股中，Silexion Therapeutics Corp、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 涨幅较大，Silexion Therapeutics Corp、60 Degrees Pharmaceuticals, Inc.、Vincerx Pharma, Inc.较为活跃，换手率分别为7842.66%、2385.55%、791.10%，振幅较大的相关个股有Ocean Biomedical Inc C/Wts 14/02/2028 、Ocean Biomedical, Inc.、Silexion Therapeutics Corp，振幅分别为185.36%、124.00%、119.26%。Kiora Pharmaceuticals, Inc.公司简介：Kiora Pharmaceuticals Inc 是一家临床阶段的生物技术公司，致力于开发和商业化用于治疗孤儿性视网膜疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130043331a233a2f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130043331a233a2f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KPRX","BK4007","KPHCW","KPHMW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507548510","title":"Kiora Pharmaceuticals, Inc.盘中异动 急速跳水5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507548510","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507548510?lang=zh_cn&edition=full","pubTime":"2025-01-28 23:10","pubTimestamp":1738077050,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日23时10分，Kiora Pharmaceuticals, Inc.股票出现波动，股价急速下挫5.00%。Kiora Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.30%。其相关个股中，Silexion Therapeutics Corp、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Hepion Pharmaceuticals, Inc.涨幅较大，Silexion Therapeutics Corp、Hepion Pharmaceuticals, Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为3122.95%、1927.49%、252.28%，振幅较大的相关个股有Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Silexion Therapeutics Corp、Hepion Pharmaceuticals, Inc.，振幅分别为122.16%、68.95%、44.85%。Kiora Pharmaceuticals, Inc.公司简介：Kiora Pharmaceuticals Inc 是一家临床阶段的生物技术公司，致力于开发和商业化用于治疗孤儿性视网膜疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501282310519612f936&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501282310519612f936&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KPHCW","KPRX","KPHMW","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2504192951","title":"Kiora Pharmaceuticals, Inc.盘中异动 股价大涨5.14%报3.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2504192951","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2504192951?lang=zh_cn&edition=full","pubTime":"2025-01-18 01:18","pubTimestamp":1737134308,"startTime":"0","endTime":"0","summary":"北京时间2025年01月18日01时18分，Kiora Pharmaceuticals, Inc.股票出现异动，股价急速拉升5.14%。Kiora Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.70%。Kiora Pharmaceuticals, Inc.公司简介：Kiora Pharmaceuticals Inc 是一家临床阶段的生物技术公司，致力于开发和商业化用于治疗孤儿性视网膜疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501180118289607bcaa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501180118289607bcaa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KPRX","BK4007","KPHCW","KPHMW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503564059","title":"Kiora Pharmaceuticals, Inc.盘中异动 早盘快速拉升6.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503564059","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503564059?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:33","pubTimestamp":1736951608,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时33分，Kiora Pharmaceuticals, Inc.股票出现异动，股价大幅拉升6.54%。Kiora Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.84%。其相关个股中，Exicure, Inc.、Allovir, Inc.、Cabaletta Bio, Inc.涨幅较大，Windtree Therapeutics, Inc.、Phio Pharmaceuticals Corp.、Oncolytics Biotech Inc.较为活跃，换手率分别为185.53%、57.39%、35.56%，振幅较大的相关个股有Onconetix, Inc.、Eterna Therapeutics Inc.、Klotho Neurosciences, Inc.，振幅分别为14.29%、12.79%、12.00%。Kiora Pharmaceuticals, Inc.公司简介：Kiora Pharmaceuticals Inc 是一家临床阶段的生物技术公司，致力于开发和商业化用于治疗孤儿性视网膜疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223328a222feae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223328a222feae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KPRX","BK4007","KPHMW","KPHCW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503250579","title":"Kiora Pharmaceuticals, Inc.盘中异动 临近午盘急速跳水5.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503250579","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503250579?lang=zh_cn&edition=full","pubTime":"2025-01-15 00:44","pubTimestamp":1736873090,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日00时44分，Kiora Pharmaceuticals, Inc.股票出现波动，股价快速下挫5.57%。Kiora Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.40%。其相关个股中，Eterna Therapeutics Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 、Jasper Therapeutics Inc C/Wts 24/09/2026 涨幅较大，Eterna Therapeutics Inc.、Phio Pharmaceuticals Corp.、Soligenix, Inc.较为活跃，换手率分别为912.12%、479.18%、410.63%，振幅较大的相关个股有Eterna Therapeutics Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Nls Pharmaceutics Ltd C/Wts 02/02/2026，振幅分别为170.74%、60.08%、60.00%。Kiora Pharmaceuticals, Inc.公司简介：Kiora Pharmaceuticals Inc 是一家临床阶段的生物技术公司，致力于开发和商业化用于治疗孤儿性视网膜疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115004451986619eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115004451986619eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KPHCW","KPHMW","BK4007","KPRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503051583","title":"Kiora Pharmaceuticals, Inc.盘中异动 早盘大幅下跌6.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503051583","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503051583?lang=zh_cn&edition=full","pubTime":"2025-01-13 22:41","pubTimestamp":1736779264,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日22时41分，Kiora Pharmaceuticals, Inc.股票出现异动，股价急速下跌6.63%。Kiora Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.31%。其相关个股中，Salarius Pharmaceuticals, Inc.、Phio Pharmaceuticals Corp.、Kairos Pharma, Ltd.涨幅较大，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为4029.65%、2318.34%、400.68%，振幅较大的相关个股有Salarius Pharmaceuticals, Inc.、Champions Oncology, Inc.、Phio Pharmaceuticals Corp.，振幅分别为104.79%、102.87%、67.46%。Kiora Pharmaceuticals, Inc.公司简介：Kiora Pharmaceuticals Inc 是一家临床阶段的生物技术公司，致力于开发和商业化用于治疗孤儿性视网膜疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113224104a2204206&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113224104a2204206&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","KPHCW","KPRX","KPHMW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502867197","title":"Kiora Pharmaceuticals, Inc.盘中异动 急速跳水5.52%报3.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502867197","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2502867197?lang=zh_cn&edition=full","pubTime":"2025-01-10 22:38","pubTimestamp":1736519883,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日22时38分，Kiora Pharmaceuticals, Inc.股票出现异动，股价快速下跌5.52%。Kiora Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.70%。其相关个股中，Precision Biosciences, Inc.、Jasper Therapeutics Inc C/Wts 24/09/2026 、Zyversa Therapeutics, Inc.涨幅较大，Zyversa Therapeutics, Inc.、Precision Biosciences, Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为1014.50%、152.64%、147.98%，振幅较大的相关个股有Conduit Pharmaceuticals Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Zyversa Therapeutics, Inc.，振幅分别为30.12%、25.00%、24.58%。Kiora Pharmaceuticals, Inc.公司简介：Kiora Pharmaceuticals Inc 是一家临床阶段的生物技术公司，致力于开发和商业化用于治疗孤儿性视网膜疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110223803aba6048c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110223803aba6048c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KPRX","KPHMW","KPHCW","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501751137","title":"Kiora Pharmaceuticals, Inc.盘中异动 股价大跌5.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501751137","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501751137?lang=zh_cn&edition=full","pubTime":"2025-01-08 22:58","pubTimestamp":1736348325,"startTime":"0","endTime":"0","summary":"北京时间2025年01月08日22时58分，Kiora Pharmaceuticals, Inc.股票出现异动，股价急速下挫5.47%。Kiora Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。其相关个股中，Sana Biotechnology, Inc.、Silo Pharma, Inc.、Vir Biotechnology, Inc.涨幅较大，Silo Pharma, Inc.、60 Degrees Pharmaceuticals, Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为2041.41%、549.66%、521.06%，振幅较大的相关个股有Silo Pharma, Inc.、Sana Biotechnology, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为135.78%、119.39%、68.53%。Kiora Pharmaceuticals, Inc.公司简介：Kiora Pharmaceuticals Inc 是一家临床阶段的生物技术公司，致力于开发和商业化用于治疗孤儿性视网膜疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108225845985f7dfb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108225845985f7dfb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KPHMW","KPHCW","BK4007","KPRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501256252","title":"Kiora Pharmaceuticals, Inc.盘中异动 早盘急速上涨5.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501256252","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501256252?lang=zh_cn&edition=full","pubTime":"2025-01-06 23:29","pubTimestamp":1736177365,"startTime":"0","endTime":"0","summary":"北京时间2025年01月06日23时29分，Kiora Pharmaceuticals, Inc.股票出现异动，股价急速拉升5.98%。Kiora Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.26%。其相关个股中，Scisparc Ltd.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 涨幅较大，Scisparc Ltd.、Cns Pharmaceuticals, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为1115.30%、301.36%、95.94%，振幅较大的相关个股有Scisparc Ltd.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 ，振幅分别为176.15%、71.31%、54.46%。Kiora Pharmaceuticals, Inc.公司简介：Kiora Pharmaceuticals Inc 是一家临床阶段的生物技术公司，致力于开发和商业化用于治疗孤儿性视网膜疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106232925a217a413&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106232925a217a413&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KPHMW","BK4007","KPRX","KPHCW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2500974189","title":"Kiora Pharmaceuticals, Inc.盘中异动 临近午盘急速上涨5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2500974189","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2500974189?lang=zh_cn&edition=full","pubTime":"2025-01-03 00:55","pubTimestamp":1735836942,"startTime":"0","endTime":"0","summary":"北京时间2025年01月03日00时55分，Kiora Pharmaceuticals, Inc.股票出现波动，股价快速上涨5.15%。Kiora Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.67%。其相关个股中，Revelation Biosciences Inc C/Wts 10/01/2027 、Celularity Inc C/Wts 16/07/2026 、Apollomics Inc C/Wts 01/04/2028 涨幅较大，Revelation Biosciences, Inc.、Mustang Bio, Inc.、知临集团较为活跃，换手率分别为1188.36%、275.44%、201.38%，振幅较大的相关个股有Revelation Biosciences Inc C/Wts 10/01/2027 、Mustang Bio, Inc.、Revelation Biosciences, Inc.，振幅分别为170.00%、146.61%、135.14%。Kiora Pharmaceuticals, Inc.公司简介：Kiora Pharmaceuticals Inc 是一家临床阶段的生物技术公司，致力于开发和商业化用于治疗孤儿性视网膜疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010300554298591b13&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010300554298591b13&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KPHCW","BK4007","KPRX","KPHMW"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kiorapharma.com","stockEarnings":[{"period":"1week","weight":-0.0337},{"period":"1month","weight":0.0279},{"period":"3month","weight":-0.019},{"period":"6month","weight":0.3299},{"period":"1year","weight":-0.0883},{"period":"ytd","weight":0.3096}],"compareEarnings":[{"period":"1week","weight":-0.0042},{"period":"1month","weight":0.0029},{"period":"3month","weight":0.0258},{"period":"6month","weight":0.1649},{"period":"1year","weight":0.1429},{"period":"ytd","weight":0.1204}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Kiora Pharmaceuticals, Inc.于2004年12月26日以EyeGate Pharmaceuticals, Inc.的名义成立为特拉华州公司，并于2021年11月8日起更名为Kiora Pharmaceuticals, Inc.。该公司是一家临床阶段的专业制药公司专注于开发和商业化用于治疗眼疾的疗法和药物输送。","yearOnYearQuotes":[{"month":1,"riseRate":0.545455,"avgChangeRate":-0.048658},{"month":2,"riseRate":0.454545,"avgChangeRate":0.102841},{"month":3,"riseRate":0.090909,"avgChangeRate":-0.12348},{"month":4,"riseRate":0.545455,"avgChangeRate":0.025472},{"month":5,"riseRate":0.363636,"avgChangeRate":-0.061181},{"month":6,"riseRate":0.090909,"avgChangeRate":-0.149193},{"month":7,"riseRate":0.181818,"avgChangeRate":-0.147068},{"month":8,"riseRate":0.25,"avgChangeRate":-0.104847},{"month":9,"riseRate":0.416667,"avgChangeRate":-0.012368},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.029259},{"month":11,"riseRate":0.363636,"avgChangeRate":0.072057},{"month":12,"riseRate":0.363636,"avgChangeRate":0.047992}],"exchange":"NASDAQ","name":"Kiora Pharmaceuticals","nameEN":"Kiora Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Kiora Pharmaceuticals(KPRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Kiora Pharmaceuticals(KPRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Kiora Pharmaceuticals,KPRX,Kiora Pharmaceuticals股票,Kiora Pharmaceuticals股票老虎,Kiora Pharmaceuticals股票老虎国际,Kiora Pharmaceuticals行情,Kiora Pharmaceuticals股票行情,Kiora Pharmaceuticals股价,Kiora Pharmaceuticals股市,Kiora Pharmaceuticals股票价格,Kiora Pharmaceuticals股票交易,Kiora Pharmaceuticals股票购买,Kiora Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Kiora Pharmaceuticals(KPRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Kiora Pharmaceuticals(KPRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}